These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


293 related items for PubMed ID: 7218764

  • 1. Dapsone haemolysis in leprosy. A preliminary report.
    Menezes S, Rege VL, Sehgal VN.
    Lepr India; 1981 Jan; 53(1):63-9. PubMed ID: 7218764
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dapsone induced hypohaptoglobinemia in lepromatous leprosy patients.
    Sritharan V, Bharadwaj VP, Venkatesan K, Girdhar BK.
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):307-10. PubMed ID: 7198620
    [Abstract] [Full Text] [Related]

  • 5. Haemolytic effects of DDS in leprosy patients.
    Khaire DS, Magar NG.
    Indian J Med Res; 1972 Oct; 60(10):1510-9. PubMed ID: 4661662
    [No Abstract] [Full Text] [Related]

  • 6. [Vitamin E as protective agent against hemolysis in leprosy patients under dapsone treatment].
    Lardo MM, Díaz NB, Artaza JR, Carbia CD, Nazer R, Valdez R.
    Medicina (B Aires); 1997 Oct; 57(2):150-4. PubMed ID: 9532824
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dapsone syndrome in Goa.
    Rege VL, Shukla P, Mascarenhas MF.
    Indian J Lepr; 1994 Oct; 66(1):59-64. PubMed ID: 7983393
    [Abstract] [Full Text] [Related]

  • 9. Vitamin E and dapsone-induced hemolysis.
    Kelly JW, Scott J, Sandland M, Van der Weyden MB, Marks R.
    Arch Dermatol; 1984 Dec; 120(12):1582-4. PubMed ID: 6508329
    [Abstract] [Full Text] [Related]

  • 10. Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity.
    Ranawaka RR, Mendis S, Weerakoon HS.
    Lepr Rev; 2008 Dec; 79(4):436-40. PubMed ID: 19274991
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dapsone syndrome--a five year retrospective analysis.
    Kumar RH, Kumar MV, Thappa DM.
    Indian J Lepr; 1998 Dec; 70(3):271-6. PubMed ID: 9801899
    [Abstract] [Full Text] [Related]

  • 13. Incidence of anemia in leprosy patients treated with dapsone.
    Puavilai S, Chutha S, Polnikorn N, Timpatanapong P, Tasanapradit P, Charuwichitratana S, Boonthanom A, Wongwaisayawan H.
    J Med Assoc Thai; 1984 Jul; 67(7):404-7. PubMed ID: 6512448
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S, Somasiri KG, Chularatna W.
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.